Pharmidex attending Biowales 2015
March 4, 2015

Leading event for Life sciences sector in Wales between 4th & 5th March 2015

BioWales 2015 - 4th & 5th March 2015

The leading event for the life sciences sector in Wales this year will focus on the life sciences supply chain providing practical commercial opportunities for growth through novel routes to market in the private sector and NHS.


An international line-up of speakers and industry experts will deliver keynote addresses and lead the showcase presentations and discussions around supply chain opportunities and development. 


The showcase sessions will provide the opportunity to hear from the big names, present your ideas, products and plans and engage in the wider debate. Key themes will focus on commercialisation and routes to market, together with financing the deal. 


BioWales 2015 sees the return of a highlight from last year’s conference – the Dragon’s Den style pitches showcasing innovative new business ideas face to face with expert investors.


For more information please see: https://biowales.com/en/.

November 5, 2025
We’re excited to welcome Grace Horne as our new Bioanalytical Scientist! 🎉 Grace brings great enthusiasm and passion for science, and we’re confident she’ll make a fantastic contribution to our team. Welcome aboard, Grace, we’re thrilled to have you with us! 💜
November 4, 2025
We’re pleased to share that Janette Dalay Robertson , Business Development Manager at Pharmidex , will attend the DDW Turning Science into Business Symposium 2025 on Tuesday, 4th November, at the The Francis Crick Institute , London. Janette looks forward to connecting with industry leaders and exploring new collaboration opportunities.
November 3, 2025
We’re delighted to announce that Pharmidex will present our poster "Driving breakthroughs in Parkinson’s & neurodegeneration research” at the upcoming RSC BMCS meeting. With over 23 years of CNS expertise, we support biopharma partners in developing new therapies for Parkinson’s disease and tauopathies, through: 🔹 Parkinson’s & neurodegeneration models 🔹 Transgenic CNS lines (incl. 5xFAD) 🔹 Biomarker & BBB penetration studies Join us in Cambridge to explore how our GLP-accredited CNS platforms accelerate discovery and development.
More Posts